Shayne & Jacobs LLC’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.79M Hold
9,060
– – 0.83% 25
2026
Q2
$2.54M Sell
9,060
-50
-0.5% -$13.1K 0.75% 30
2026
Q1
$2.43M Hold
9,110
– – 0.75% 25
2025
Q4
$2.29M Hold
9,110
– – 0.69% 27
2025
Q3
$2.62M Hold
9,110
– – 0.81% 21
2025
Q2
$2.39M Hold
9,110
– – 0.79% 22
2025
Q1
$2.12M Sell
9,110
-95
-1% -$23.1K 0.52% 24
2024
Q4
$2.11M Buy
9,205
+40
+0.4% +$9.18K 0.55% 25
2024
Q3
$2.05M Buy
9,165
+130
+1% +$28.6K 0.51% 28
2024
Q2
$1.84M Buy
9,035
+740
+9% +$151K 0.51% 28
2024
Q1
$1.81M Sell
8,295
-70
-0.8% -$15.4K 0.49% 30
2023
Q4
$1.9M Hold
8,365
– – 0.59% 29
2023
Q3
$1.68M Buy
+8,365
New +$1.76M 0.56% 28

Other funds holding LH

Shayne & Jacobs LLC's LH Position: Q3 2026 in Review

Shayne & Jacobs LLC held its Labcorp (LH) position steady in Q3 2026 at 9,060 shares worth $2.79M. The position accounts for 0.83% of the portfolio, ranked #25.

Shayne & Jacobs LLC first reported a position in LH in Q3 2023 and has held it in 13 quarters since. 384 funds tracked by Wall St. Rank hold LH as of Q3 2026.

  • Shayne & Jacobs LLC held 9,060 shares of Labcorp worth $2.79M as of Q3 2026.
  • Shayne & Jacobs LLC left its Labcorp share count unchanged in Q3 2026.
  • Labcorp made up 0.83% of Shayne & Jacobs LLC's portfolio in Q3 2026, its #25 holding.
  • Shayne & Jacobs LLC first reported a position in Labcorp in Q3 2023 and has held it in 13 quarters since.
  • 384 funds tracked by Wall St. Rank held Labcorp as of Q3 2026.

Based on Shayne & Jacobs LLC's 13F filing for Q3 2026, filed 21 Oct 2026.